News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,077 Results
Type
Article (88167)
Company Profile (825)
Press Release (784065)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18432)
Job Trends (17439)
News (398113)
Policy (39994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (163)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (376)
Approvals (18632)
Artificial intelligence (676)
Autoimmune disease (191)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (175)
Brain cancer (69)
Breast cancer (694)
Cancer (5316)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (67)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77378)
Collaboration (1939)
Company closure (5)
Compensation (1225)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (957)
Cystic fibrosis (155)
Data (6649)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7317)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100697)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135779)
Executive appointments (1069)
FDA (21787)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1634)
Gene editing (230)
Generative AI (71)
Gene therapy (713)
GLP-1 (1164)
Government (5479)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (90)
Immunology and inflammation (309)
Immuno-oncology (75)
Indications (131)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (396)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (15087)
Medtech (15151)
Mergers & acquisitions (23035)
Metabolic disorders (1472)
mRNA (201)
Multiple sclerosis (178)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3239)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (719)
Opinion (347)
Ovarian cancer (174)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (317)
Partnered (39)
Patents (545)
Patient recruitment (547)
Peanut (65)
People (67135)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23908)
Phase 2 (33576)
Phase 3 (25297)
Pipeline (5991)
Policy (357)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (272)
Psychedelics (60)
Radiopharmaceuticals (317)
Rare diseases (1002)
Real estate (7445)
Recruiting (81)
Regulatory (29326)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1190)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (76)
Last 7 days (978)
Last 30 days (2952)
Last 365 days (32710)
2026 (5390)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51684)
Australia (9082)
California (12149)
Canada (3460)
China (1227)
Colorado (514)
Connecticut (526)
Delaware (361)
Europe (118912)
Florida (1803)
Georgia (394)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (80)
Indiana (574)
Iowa (24)
Japan (464)
Kansas (135)
Kentucky (47)
Louisiana (32)
Maine (84)
Maryland (1509)
Massachusetts (8897)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3266)
New Mexico (33)
New York (3202)
North Carolina (1675)
North Dakota (10)
Northern California (5875)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2417)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4703)
Tennessee (185)
Texas (1909)
United States (43689)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,077 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
March 2, 2026
·
14 min read
Press Releases
IRLAB Participates in Life Science Day in Gothenburg on March 4, 2026
March 2, 2026
·
1 min read
Press Releases
Alligator Bioscience Comments on Henlius Dosing First Patient in Phase 2/3 Breast Cancer Study of HLX22
March 2, 2026
·
2 min read
Press Releases
Genflow Biosciences PLC Announces Receipt of First Tranche of Grant
March 2, 2026
·
5 min read
Press Releases
Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS
March 2, 2026
·
6 min read
Press Releases
Egle Therapeutics and Consortium Partners Awarded €8 Million Grant from Horizon Europe to Advance Clinical Development of EGL-001 in Neoadjuvant Head and Neck Cancer
March 2, 2026
·
4 min read
Press Releases
Paul Chaplin Steps Down as CEO of Bavarian Nordic
March 2, 2026
·
3 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib confirms its potential as first and only BTK inhibitor for relapsing and primary progressive MS in third positive Phase III study (FENhance 1)
March 2, 2026
·
9 min read
Press Releases
VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.
March 2, 2026
·
10 min read
Press Releases
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
March 2, 2026
·
7 min read
1 of 87,308
Next
